Etoposide and cisplatin (EP) for metastatic good-risk germ cell tumors (GCTs): The Memorial Sloan-Kettering Cancer Center (MSKCC) experience in 944 patients (pts) Meeting Abstract


Authors: Funt, S.; McHugh, D. J.; Tsai, S.; O'Donnell, D.; Knezevic, A.; Patil, S.; Silber, D.; Reuter, V. E.; Sheinfeld, J.; Carver, B. S.; Carousso, M.; Motzer, R. J.; Bajorin, D. F.; Bosl, G. J.; Feldman, D. R.
Abstract Title: Etoposide and cisplatin (EP) for metastatic good-risk germ cell tumors (GCTs): The Memorial Sloan-Kettering Cancer Center (MSKCC) experience in 944 patients (pts)
Meeting Title: 54th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 15 Suppl.
Meeting Dates: 2018 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-05-20
Start Page: 253s
Language: English
ACCESSION: WOS:000442916002077
DOI: 10.1200/JCO.2018.36.15_suppl.4550
PROVIDER: wos
Notes: Meeting Abstract: 4550 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sujata Patil
    511 Patil
  2. Dean Bajorin
    663 Bajorin
  3. Robert Motzer
    1251 Motzer
  4. Darren Richard Feldman
    348 Feldman
  5. Joel Sheinfeld
    258 Sheinfeld
  6. Brett Stewart Carver
    144 Carver
  7. Victor Reuter
    1234 Reuter
  8. George Bosl
    431 Bosl
  9. Samuel Aaron Funt
    143 Funt
  10. Andrea Knezevic
    109 Knezevic
  11. Deaglan Joseph McHugh
    45 McHugh
  12. Deborah Scaler Silber
    9 Silber
  13. Stephanie Tsai
    5 Tsai